A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers

Clinical trial NCT06120504 · TERMINATED

Trial details

NCT number: NCT06120504
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Cutaneous Hodgkin Disease Lymphoma, T-Cell, Peripheral Lymphoma, Large-Cell, Anaplastic Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin

Start date: 2024-02-29
Primary completion: 2025-12-10
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.